ENLV · Enlivex Therapeutics Ltd.

Summary

Enlivex Therapeutics Ltd. reported that the Rain Foundation launched an OpenClaw and AI agent interface enabling anyone to create live prediction markets via a single prompt without coding or gatekeepers, and announced a $5 million grant program for developers. As a major RAIN token holder, Enlivex views this as enhancing Rain's position and potential revenue growth via 2.5% trading volume buy-and-burn.

Key takeaways

• Rain Foundation launched OpenClaw and AI agent interface for single-prompt prediction market creation
• Rain Foundation announced $5 million grant program for developers building on Rain protocol
• Enlivex is a major holder of RAIN in its treasury portfolio
• Rain protocol appropriates 2.5% of total trading volume for automatic RAIN token buy-and-burn
• Announcement dated March 26, 2026 from Nes-Ziona, Israel